N-(2-{[5-Bromo-2-(piperidin-1-yl)pyrimidin-4-yl]sulfan­yl}-4-meth­oxy­phen­yl)benzene­sulfonamide

The title compound, C22H23BrN4O3S2, crystallizes with two mol­ecules, A and B, in the asymmetric unit. In one of these, the meth­oxy group is disordered over two sets of sites in a 0.565 (9):0.435 (9) ratio. The benzene rings bridged by the sulfonamide group are tilted relative to each other by 37.4...

Full description

Bibliographic Details
Main Authors: Kumar, Mohan, Mallesha, L., Sridhar, M. A., Kapoor, Kamini, Gupta, Vivek K., Kant, Rajni
Format: Online
Language:English
Published: International Union of Crystallography 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515297/